Decorin and colchicine as potential treatments for post-haemorrhagic ventricular dilatation in a neonatal rat model

Neonatology

Volumn 100, Issue 3, 2011, Pages 271-276

  Hoque, Nicholas ^a   Thoresen, Marianne ^a,b   Aquilina, Kristian ^a   Hogan, Sarah ^a   Whitelaw, Andrew ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Colchicine; Decorin; Hydrocephalus; Intraventricular haemorrhage; Newborn; Post haemorrhagic ventricular dilatation; Transforming growth factor

Indexed keywords

COLCHICINE; DECORIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN VENTRICLE DILATATION; BRAIN VENTRICLE PERITONEUM SHUNT; CONTROLLED STUDY; DOWN REGULATION; DRUG TOLERABILITY; FEMALE; GROWTH RATE; NEWBORN; NONHUMAN; PATHOGENESIS; POST HEMORRHAGIC VENTRICULAR DILATATION; POST HEMORRHAGIC VENTRICULAR DILATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; COLCHICINE; DECORIN; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; GRAVITY SENSING; INJECTIONS, INTRAVENTRICULAR; LONGEVITY; MOTOR ACTIVITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFLEX, RIGHTING; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; RATTUS;

EID: 79959385369     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000327842     Document Type: Article

References (30)

1. Volpe J: Intracranial hemorrhage: germinal matrix - intraventricular hemorrhage of the premature infant; in Neurology of the Newborn. Philadelphia, W.B. Saunders, 2008, pp 517-588.
2. Randomised trial of early tapping in neonatal posthaemorrhagic ventricular dilatation. Ventriculomegaly Trial Group. Arch Dis Child 1990;65:3-10.
3. Kennedy CR, Ayers S, Campbell MJ, Elbourne D, Hope P, Johnson A: Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy: follow-up at 1 year. Pediatrics 2001;108:597-607. (Pubitemid 32786586)
4. Whitelaw A, Evans D, Carter M, Thoresen M, Wroblewska J, Mandera M, Swietlinski J, Simpson J, Hajivassiliou C, Hunt LP, Pople I: Randomized clinical trial of prevention of hydrocephalus after intraventricular hemorrhage in preterm infants: brain-washing versus tapping fluid. Pediatrics 2007;119:e1071-e1078. (Pubitemid 46715644)
5. Larroche JC: Post-haemorrhagic hydrocephalus in infancy. Anatomical study. Biol Neonate 1972;20:287-299.
6. Whitelaw A, Christie S, Pople I: Transforming growth factor-beta1: a possible signal molecule for posthemorrhagic hydrocephalus? Pediatr Res 1999;46:576-580. (Pubitemid 29496487)
7. Cherian SS, Love S, Silver IA, Porter HJ, Whitelaw AG, Thoresen M: Posthemorrhagic ventricular dilation in the neonate: development and characterization of a rat model. J Neuropathol Exp Neurol 2003;62:292-303. (Pubitemid 36330680)
8. Crews L, Wyss-Coray T, Masliah E: Insights into the pathogenesis of hydrocephalus from transgenic and experimental animal models. Brain Pathol 2004;14:312-316. (Pubitemid 39095995)
9. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW: Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res 1999;30:77-105. (Pubitemid 29331517)
10. Logan A, Green J, Hunter A, Jackson R, Berry M: Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2. Eur J Neurosci 1999;11:2367-2374. (Pubitemid 29292331)
11. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990;346:281-284.
12. Biglari A, Bataille D, Naumann U, Weller M, Zirger J, Castro MG, Lowenstein PR: Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model. Cancer Gene Ther 2004;11:721-732. (Pubitemid 39488470)
13. Logan A, Baird A, Berry M: Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp Neurol 1999;159:504-510. (Pubitemid 29485236)
14. Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJ: Decorin suppresses neurocan, brevican, phosphacan and ng2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci 2004;19:1226-1242. (Pubitemid 38387200)
15. Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J: The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 2001;29:394-402. (Pubitemid 32661352)
16. Ozkaya N, Yalcinkaya F: Colchicine treatment in children with familial Mediterranean fever. Clin Rheumatol 2003;22:314-317. (Pubitemid 37483627)
17. Almasio PL, Floreani A, Chiaramonte M, Provenzano G, Battezzati P, Crosignani A, Podda M, Todros L, Rosina F, Saccoccio G, Manenti F, Ballardini G, Bianchi FP, Scheuer PJ, Davies SE, Craxi A: Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis. Aliment Pharmacol Ther 2000;14:1645-1652. (Pubitemid 32011738)
18. Chung KY, Kang DS: Regulation of type Icollagen and interstitial collagenase mRNA expression in human dermal fibroblasts by colchicine and D-penicillamine. Yonsei Med J 1999;40:490-495. (Pubitemid 29523623)
19. Lee SJ, Kim YG, Kang KW, Kim CW, Kim SG: Effects of colchicine on liver functions of cirrhotic rats: beneficial effects result from stellate cell in activation and inhibition of TGF beta1 expression. Chem Biol Interact 2004;147:9-21. (Pubitemid 38076846)
20. Cisternino S, Rousselle C, Debray M, Scherrmann JM: In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier. Pharm Res 2003;20:1607-1611. (Pubitemid 37268276)
21. Cherian S, Thoresen M, Silver IA, Whitelaw A, Love S: Transforming growth factor-betas in a rat model of neonatal posthaemorrhagic hydrocephalus. Neuropathol Appl Neurobiol 2004;30:585-600. (Pubitemid 39564178)
22. Aquilina K, Hobbs C, Tucker A, Whitelaw A, Thoresen M: Do drugs that block transforming growth factor beta reduce posthaemorrhagic ventricular dilatation in a neonatal rat model? Acta Paediatr 2008;97:1181-1186.
23. Lubics A, Reglodi D, Tamas A, Kiss P, Szalai M, Szalontay L, Lengvari I: Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic-ischemic injury. Behav Brain Res 2005;157:157-165. (Pubitemid 40029710)
24. Altman D: Practical Statistics for Medical Research. London, Chapman Hall, 1991.
25. Flood C, Akinwunmi J, Lagord C, Daniel M, Berry M, Jackowski A, Logan A: Transforming growth factor-beta1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage: titers derived from exogenous and endogenous sources. J Cereb Blood Flow Metab 2001;21:157-162. (Pubitemid 32143977)
26. Galbreath E, Kim SJ, Park K, Brenner M, Messing A: Overexpression of TGF-beta 1 in the central nervous system of transgenic mice results in hydrocephalus. J Neuropathol Exp Neurol 1995;54:339-349.
27. Kanaji M, Tada T, Kobayashi S: A murine model of communicating hydrocephalus: role of TGF-beta1. J Clin Neurosci 1997;4:51-56. (Pubitemid 127674789)
28. Lagord C, Berry M, Logan A: Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol Cell Neurosci 2002;20:69-92. (Pubitemid 34634329)
29. Shittu EA, Yang CP, Roberts IS, Bell EB, Brenchley P, Roberts T, Wood PJ: Inhibition of chronic vascular rejection by donor-specific blood transfusion is associated with a reduction in transforming growth factorbeta1 expression. Transplantation 2002;73:1573-1581. (Pubitemid 34568668)
30. Heep A, Stoffel-Wagner B, Bartmann P, Benseler S, Schaller C, Groneck P, Obladen M, Felderhoff-Mueser U: Vascular endothelial growth factor and transforming growth factor-beta1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus. Pediatr Res 2004;56:768-774. (Pubitemid 39403404)